Author

D. Murillo

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Assay:DNA methylation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

A. Astudillo· 1 shared A. Brana· 1 shared A. F. Fernandez· 1 shared A. Rodriguez· 1 shared B. Gallego· 1 shared C. Huergo· 1 shared C. Robledo· 1 shared D. Heymann· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Astudillo

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

A personalized medicine approach identifies enasidenib as an efficient treatment for IDH2 mutant chondrosarcoma

V. Rey, J. Tornin, J. J. Alba-Linares, C. Robledo, D. Murillo, A. Rodriguez, B. Gallego, C. Huergo, A. Brana, A. Astudillo, D. Heymann, A. F. Fernandez, M. F. Fraga, J. Alonso, R. Rodriguez

This study identifies enasidenib as an effective treatment for IDH2 mutant chondrosarcoma through personalized medicine approaches involving sequencing, cell line models, and in vitro/in vivo testing.

eBioMedicine · Apr 1, 2024Peer-reviewedCancer Biology